Výpis publikací

FRÖHLICH, Jan; Niccolo LIORNI; Manuel MANGONI; Gabriela LOCHMANOVÁ; Pavlína PÍREK; Nikola KAŠTÁNKOVÁ; Pille PATA; Jan KUČERA; George N CHALDAKOV; Anton B TONCHEV; Illar PATA; Vera GORBUNOVA; Eric LEIRE; Zbyněk ZDRÁHAL; Tommaso MAZZA a Manlio VINCIGUERRA. Epigenetic and transcriptional control of adipocyte function by centenarian-associated SIRT6 N308K/A313S mutant. CLINICAL EPIGENETICS. LONDON: BMC, 2024, roč. 16, č. 1, s. 1-17. ISSN 1868-7075. Dostupné z: https://doi.org/10.1186/s13148-024-01710-1.

SMETANA, Jan; Jan FRÖHLICH; Romana ZAORALOVÁ; Vladimíra VALLOVÁ; Henrieta GREŠLIKOVÁ; Renata KUPSKÁ; Pavel NĚMEC; Aneta MIKULÁŠOVÁ; Martina ALMAŠI; Luděk POUR; Zdeněk ADAM; Viera SANDECKÁ; Lenka ZAHRADOVÁ; Roman HÁJEK a Petr KUGLÍK. Genome-Wide Screening of Cytogenetic Abnormalities in Multiple Myeloma Patients Using Array-CGH Technique: A Czech Multicenter Experience. BioMed Research International. Hindawi Publishing Corporation, 2014, Neuveden, MAY, s. "nestrankovano", 9 s. ISSN 2314-6133. Dostupné z: https://doi.org/10.1155/2014/209670.

SMETANA, Jan; Kristina BERÁNKOVÁ; Romana ZAORALOVÁ; Pavel NĚMEC; Henrieta GREŠLIKOVÁ; Renata KUPSKÁ; Aneta MIKULÁŠOVÁ; Jan FRÖHLICH; Sabina ŠEVČÍKOVÁ; Lenka ZAHRADOVÁ; Marta KREJČÍ; Viera SANDECKÁ; Martina ALMAŠI; Petra KAISAROVÁ; Hana MELICHAROVÁ; Zdeněk ADAM; Miroslav PENKA; Jiří JARKOVSKÝ; Arthur JURCZYSZYN; Roman HÁJEK a Petr KUGLÍK. Gain(1)(q21) is an Unfavorable Genetic Prognostic Factor for Patients With Relapsed Multiple Myeloma Treated With Thalidomide but Not for Those Treated With Bortezomib. Clinical lymphoma, myeloma & leukemia. United States: Elsevier, 2013, roč. 13, č. 2, s. 123-130. ISSN 2152-2650. Dostupné z: https://doi.org/10.1016/j.clml.2012.11.012.

SMETANA, Jan; Jan FRÖHLICH; Vladimíra VRANOVÁ; Aneta MIKULÁŠOVÁ; Petr KUGLÍK a Roman HÁJEK. Oligonucleotide-based Array CGH as a Diagnostic Tool in Multiple Myeloma Patients. Klinická onkologie. 2011, roč. 24, Suppl., s. 43-48. ISSN 0862-495X.